Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis
Completed · Phase 3
Conditions studied: Psoriatic Arthritis
In brief
This was a randomized, double-blind, active controlled, multicenter, parallel-group study evaluating secukinumab monotherapy and adalimumab monotherapy in approximately 850 patients with active psoriatic arthritis (PsA) who are naïve to biologic therapy and are intolerant or having inadequate response to conventional disease modifying anti-rheumatic drugs (also known as non-biologic DMARDs).
Key facts
- Study ID
- NCT02745080
- Run by
- Novartis Pharmaceuticals
- People needed
- 853
- Starts
- 2017-04-03
- Expected to finish
- 2019-12-30
- Last updated by the study team
- 2021-01-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Fullerton, California, United States
- Novartis Investigative Site — La Mesa, California, United States
- Novartis Investigative Site — Upland, California, United States
- Novartis Investigative Site — Bowling Green, Kentucky, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — Lincoln, Nebraska, United States
- Novartis Investigative Site — Omaha, Nebraska, United States
- Novartis Investigative Site — Rochester, New York, United States
- Novartis Investigative Site — Bethlehem, Pennsylvania, United States
- Novartis Investigative Site — Duncansville, Pennsylvania, United States
- Novartis Investigative Site — Arlington, Texas, United States
- Novartis Investigative Site — Austin, Texas, United States
- Novartis Investigative Site — Dallas, Texas, United States
- Novartis Investigative Site — Mesquite, Texas, United States
- Novartis Investigative Site — Burlington, Vermont, United States
- Novartis Investigative Site — Seattle, Washington, United States
- Novartis Investigative Site — Spokane, Washington, United States
- Novartis Investigative Site — Glendale, Wisconsin, United States
- Novartis Investigative Site — Kogarah, New South Wales, Australia
- Novartis Investigative Site — Maroochydore, Queensland, Australia
- Novartis Investigative Site — Hobart, Tasmania, Australia
- Novartis Investigative Site — Malvern East, Victoria, Australia
- Novartis Investigative Site — Pleven, Bulgaria
- Novartis Investigative Site — Plovdiv, Bulgaria
- Novartis Investigative Site — Fountain Valley, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.